Suresh Kotagal, Beth Malow, Karen Spruyt, Guanghai Wang, Carlos Ernest Bolaños Almeida, Lina Marcela Tavera Saldaña, Sarah Blunden, Indra Narang, Osman S Ipsiroglu, Oliviero Bruni, Barbara Gnidovec Strazisar, Narong Simakajornboon, Magda Lahorgue Nunes, Samuele Cortese
Though it is widely prescribed for improving sleep of children with autism and other neurogenetic disorders, there is a need for practical guidance to clinicians on the use of melatonin for managing insomnia in this population. Because data were either lacking or inconclusive, a task force was established by the International Pediatric Sleep Association (IPSA) to examine the literature based on clinical trials from 2012 onwards. A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith...
April 20, 2024: Sleep Medicine